BSJ-03-123

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameBSJ-03-123
Drug Alias NameBSJ-03-123
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionCyclin-dependent kinase 6 inhibitorsProteolysis
TargetsCyclin-dependent kinase 6
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A